Literature DB >> 7212497

Efficacy of nifedipine in rest angina refractory to propranolol and nitrates in patients with obstructive coronary artery disease.

J W Moses, J H Wertheimer, M M Bodenheimer, V S Banka, M Feldman, R H Helfant.   

Abstract

Nineteen patients with recurrent rest angina were given oral nifedipine. All patients had chest discomfort refractory to propranolol and oral or topical nitrates given to tolerance. The addition of nifedipine, 30 to 120 mg daily, abolished rest angina in 14 patients, decreased its frequency in two, and had no effect in three patients. Five of seven patients on long-term nifedipine (mean, 6.2 +/- 3.4 months) remained free of rest pain. Of seven patients who had their nifedipine dose decreased or discontinued, five had recurrent rest angina. Of the 19 patients, 16 had coronary angiography. Five had three- vessel obstructive disease (greater than 75% lesion), six had two-vessel obstructive disease, and five had one-vessel obstructive disease. The remaining three unstudied patients had pathologic Q waves in the ECG. Thus nifedipine appears to be an efficacious agent in the treatment of refractory rest angina in patients with obstructive coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7212497     DOI: 10.7326/0003-4819-94-4-425

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  8 in total

1.  Action of nifedipine in ischemic heart disease.

Authors:  D D Miller; P Théroux; D D Waters; G B Pelletier
Journal:  Can Fam Physician       Date:  1983-04       Impact factor: 3.275

Review 2.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

Review 3.  Adverse reactions to calcium antagonists.

Authors:  J G Lewis
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

4.  Long acting nifedipine in the treatment of severe hypertension.

Authors:  M Bursztyn; E Grossmann; T Rosenthal
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Calcium channel blockers.

Authors:  P C Deedwania
Journal:  West J Med       Date:  1982-07

6.  Calcium blockers for cardiac disease: therapeutic implications.

Authors:  A Dodek; J Ruedy
Journal:  Can Med Assoc J       Date:  1983-04-15       Impact factor: 8.262

Review 7.  Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1988-01       Impact factor: 3.727

8.  Attenuation of Cardiovascular Response to Direct Laryngoscopy and Intubation, Comparative Study of Lignocaine, Nifedipine, and Placebo During General Anesthesia.

Authors:  Venkata Sesha Sai Krishna Manne; Venkata Raghavendra Paluvadi
Journal:  Anesth Essays Res       Date:  2017 Jan-Mar
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.